The Latin America, Middle East and Africa Cluster Headache Market would witness market growth of 7.8% CAGR during the forecast period (2022-2028).
The cycle of a headache might be shortened by using prescription drugs. These may lessen the intensity of the headaches. Verapamil, lithium carbonate, divalproex sodium, calcium channel blockers, melatonin, and topiramate are possible treatments. In addition, a new preventative treatment is a monoclonal antibody against the calcitonin gene-related peptide (CGRP). If necessary, cluster headaches have been treated surgically in the past. The use of gentle electrical stimulation on the neck is one approach. Another inserts a medical device through the top gums to produce electrical stimulation.
A rise in the introduction of different monoclonal antibodies for cluster headaches and an increase in the number of novel medications being tested in clinical trials by significant firms are expected to benefit the market's expansion. Also, it is projected that an increase in the number of cluster headache drugs in development would fuel market growth.
Saudi Arabia Pharmaceuticals’ mission is to accelerate the development of the region's manufacturing cluster and transition to more complex goods with an emphasis on those crucial for national security. With the total net worth of $120 billion and an excellent export prospect, the Saudi pharmaceutical industry is one of the fastest-growing in the world today. The Saudi pharmaceutical sector grew by over 5% CAGR in 2018 to reach 8.2 billion dollars in sales. Up to 2025, the industry is anticipated to expand at a 5% annual pace to reach $10 Bn. The substantial investment and the growing number of initiatives by the government to develop the pharmaceutical sector will provide innovative and enhanced treatment options for the cluster headache, which will propel the market growth in the LAMEA.
The Brazil market dominated the LAMEA Cluster Headache Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $8.6 Million by 2028. The Argentina market is experiencing a CAGR of 8.3% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 7.5% during (2022 - 2028).
Based on Distribution channel, the market is segmented into Drug Stores & Retail Pharmacies, Hospital Pharmacies, and Others. Based on Type, the market is segmented Episodic, and Chronic. Based on Drug Class, the market is segmented into Triptans, Calcium Channel Blockers, Ergot Derivatives, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Cluster Headache Market is Predict to reach $437.5 Million by 2028, at a CAGR of 4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Dr. Reddy’s Laboratories Ltd., Novartis AG, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline PLC (GSK), Pfizer, Inc., Fresenius SE & Co. KGaA, Eli Lilly And Company, Grünenthal GmbH, and Arrotex Pharmaceuticals Pty Limited.
Scope of the Study
Market Segments Covered in the Report:
By Distribution channel
- Drug Stores & Retail Pharmacies
- Hospital Pharmacies
- Others
By Type
By Drug Class
- Triptans
- Calcium Channel Blockers
- Ergot Derivatives
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Dr.Reddy’s Laboratories Ltd.
- Novartis AG
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- GlaxoSmithKline PLC (GSK)
- Pfizer, Inc.
- Fresenius SE & Co. KGaA
- Eli Lilly And Company
- Grünenthal GmbH
- Arrotex Pharmaceuticals Pty Limited
TABLE 1 LAMEA Cluster Headache Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Cluster Headache Market, 2022 - 2028, USD Million
TABLE 3 LAMEA Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
TABLE 4 LAMEA Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
TABLE 5 LAMEA Drug Stores & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 6 LAMEA Drug Stores & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 7 LAMEA Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 8 LAMEA Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 9 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 10 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 11 LAMEA Cluster Headache Market by Type, 2018 - 2021, USD Million
TABLE 12 LAMEA Cluster Headache Market by Type, 2022 - 2028, USD Million
TABLE 13 LAMEA Episodic Market by Country, 2018 - 2021, USD Million
TABLE 14 LAMEA Episodic Market by Country, 2022 - 2028, USD Million
TABLE 15 LAMEA Chronic Market by Country, 2018 - 2021, USD Million
TABLE 16 LAMEA Chronic Market by Country, 2022 - 2028, USD Million
TABLE 17 LAMEA Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
TABLE 18 LAMEA Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
TABLE 19 LAMEA Triptans Market by Country, 2018 - 2021, USD Million
TABLE 20 LAMEA Triptans Market by Country, 2022 - 2028, USD Million
TABLE 21 LAMEA Calcium Channel Blockers Market by Country, 2018 - 2021, USD Million
TABLE 22 LAMEA Calcium Channel Blockers Market by Country, 2022 - 2028, USD Million
TABLE 23 LAMEA Ergot Derivatives Market by Country, 2018 - 2021, USD Million
TABLE 24 LAMEA Ergot Derivatives Market by Country, 2022 - 2028, USD Million
TABLE 25 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 26 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 27 LAMEA Cluster Headache Market by Country, 2018 - 2021, USD Million
TABLE 28 LAMEA Cluster Headache Market by Country, 2022 - 2028, USD Million
TABLE 29 Brazil Cluster Headache Market, 2018 - 2021, USD Million
TABLE 30 Brazil Cluster Headache Market, 2022 - 2028, USD Million
TABLE 31 Brazil Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
TABLE 32 Brazil Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
TABLE 33 Brazil Cluster Headache Market by Type, 2018 - 2021, USD Million
TABLE 34 Brazil Cluster Headache Market by Type, 2022 - 2028, USD Million
TABLE 35 Brazil Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
TABLE 36 Brazil Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
TABLE 37 Argentina Cluster Headache Market, 2018 - 2021, USD Million
TABLE 38 Argentina Cluster Headache Market, 2022 - 2028, USD Million
TABLE 39 Argentina Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
TABLE 40 Argentina Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
TABLE 41 Argentina Cluster Headache Market by Type, 2018 - 2021, USD Million
TABLE 42 Argentina Cluster Headache Market by Type, 2022 - 2028, USD Million
TABLE 43 Argentina Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
TABLE 44 Argentina Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
TABLE 45 UAE Cluster Headache Market, 2018 - 2021, USD Million
TABLE 46 UAE Cluster Headache Market, 2022 - 2028, USD Million
TABLE 47 UAE Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
TABLE 48 UAE Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
TABLE 49 UAE Cluster Headache Market by Type, 2018 - 2021, USD Million
TABLE 50 UAE Cluster Headache Market by Type, 2022 - 2028, USD Million
TABLE 51 UAE Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
TABLE 52 UAE Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
TABLE 53 Saudi Arabia Cluster Headache Market, 2018 - 2021, USD Million
TABLE 54 Saudi Arabia Cluster Headache Market, 2022 - 2028, USD Million
TABLE 55 Saudi Arabia Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
TABLE 56 Saudi Arabia Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
TABLE 57 Saudi Arabia Cluster Headache Market by Type, 2018 - 2021, USD Million
TABLE 58 Saudi Arabia Cluster Headache Market by Type, 2022 - 2028, USD Million
TABLE 59 Saudi Arabia Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
TABLE 60 Saudi Arabia Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
TABLE 61 South Africa Cluster Headache Market, 2018 - 2021, USD Million
TABLE 62 South Africa Cluster Headache Market, 2022 - 2028, USD Million
TABLE 63 South Africa Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
TABLE 64 South Africa Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
TABLE 65 South Africa Cluster Headache Market by Type, 2018 - 2021, USD Million
TABLE 66 South Africa Cluster Headache Market by Type, 2022 - 2028, USD Million
TABLE 67 South Africa Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
TABLE 68 South Africa Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
TABLE 69 Nigeria Cluster Headache Market, 2018 - 2021, USD Million
TABLE 70 Nigeria Cluster Headache Market, 2022 - 2028, USD Million
TABLE 71 Nigeria Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
TABLE 72 Nigeria Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
TABLE 73 Nigeria Cluster Headache Market by Type, 2018 - 2021, USD Million
TABLE 74 Nigeria Cluster Headache Market by Type, 2022 - 2028, USD Million
TABLE 75 Nigeria Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
TABLE 76 Nigeria Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
TABLE 77 Rest of LAMEA Cluster Headache Market, 2018 - 2021, USD Million
TABLE 78 Rest of LAMEA Cluster Headache Market, 2022 - 2028, USD Million
TABLE 79 Rest of LAMEA Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
TABLE 80 Rest of LAMEA Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
TABLE 81 Rest of LAMEA Cluster Headache Market by Type, 2018 - 2021, USD Million
TABLE 82 Rest of LAMEA Cluster Headache Market by Type, 2022 - 2028, USD Million
TABLE 83 Rest of LAMEA Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
TABLE 84 Rest of LAMEA Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
TABLE 85 key information – Dr. Reddy’s Laboratories Ltd.
TABLE 86 Key Information – Novartis AG
TABLE 87 Key Information – Sun Pharmaceutical Industries Ltd.
TABLE 88 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 89 Key Information – GlaxoSmithKline PLC (GSK)
TABLE 90 Key Information – Pfizer, Inc.
TABLE 91 key information – Fresenius SE & Co. KGaA
TABLE 92 Key Information – Eli Lilly And Company
TABLE 93 Key Information – Grünenthal GmbH
TABLE 94 Key Information – Arrotex Pharmaceuticals Pty Limited
List of Figures
FIG 1 Methodology for the research